Xinmin Zhao

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Shanghai Liangyou (China)

发表论文 62 篇 · 总被引 953 次 · h-index 16

代表论文

• Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor (2023 · Journal of Cancer Research and Clinical Oncology · 被引 40)
• Rare mutation-dominant compound EGFR-positive NSCLC is associated with enriched kinase domain-resided variants of uncertain significance and poor clinical outcomes (2023 · BMC Medicine · 被引 19)
• Mechanisms of Resistance to Tyrosine Kinase Inhibitors in ROS1 Fusion-Positive Nonsmall Cell Lung Cancer (2024 · Clinical Chemistry · 被引 16)
• Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA (2023 · MedComm · 被引 16)
• A phase II study of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small cell lung cancer (2022 · Thoracic Cancer · 被引 15)
• Plasma Extracellular Vesicle Long RNA in Diagnosis and Prediction in Small Cell Lung Cancer (2022 · Cancers · 被引 13)